NULISA

Beyond's analysis on NULISA

• 2026-07-11 — Alamar Biosciences’ NULISA platform gains validation as its Alzheimer’s biomarker data is slated for presentation in over 140 AAIC 2026 sessions
• 2026-07-11 — Over 140 AAIC 2026 presentations used Alamar Biosciences' NULISA data, underscoring rapid adoption of its blood-based Alzheimer's biomarker platform

Recent news mentioning NULISA

• 2026-07-29 — Alamar Biosciences 推出 NULISAseq™ Immune 340 Panel 檢測組合，為免疫蛋白質體作全面分析
• 2026-07-28 — Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome

Browse the full archive →